Neurology
Found 294 results
Filters: Keyword is Humans  [Clear All Filters]
2018
Sequeira AJ, Buchman S, Lewis A, Karceski S.  2018.  Future development of a depot antiepileptic drug: What are the ethical implications? Epilepsy Behav. 85:183-187.
Schaefer SM, Dominguez M, Moeller JJ.  2018.  The Future of the Lecture in Neurology Education.. Semin Neurol. 38(4):418-427.
Robbins MS, Rosen NL.  2018.  Headache Interest in Academic Neurology Leadership: A Cross-Sectional Study.. Headache. 58(1):102-108.
Brady E, Parikh NS, Navi BB, Gupta A, Schweitzer AD.  2018.  The imaging spectrum of posterior reversible encephalopathy syndrome: A pictorial review.. Clin Imaging. 47:80-89.
Ranganathan U, Kaunzner U, Foster S, Vartanian T, Perumal JS.  2018.  Immediate transient thrombocytopenia at the time of alemtuzumab infusion in multiple sclerosis.. Mult Scler. 24(4):540-542.
Wilcox JA, Ramakrishna R, Magge R.  2018.  Immunotherapy in Glioblastoma.. World Neurosurg. 116:518-528.
Salas RMarie E, Strowd RE, Ali I, Soni M, Schneider L, Safdieh J, Vaughn BV, Avidan AY, Jeffery JB, Gamaldo CE.  2018.  Incorporating sleep medicine content into medical school through neuroscience core curricula.. Neurology. 91(13):597-610.
Mosconi L, Rahman A, Diaz I, Wu X, Scheyer O, Hristov HWebb, Vallabhajosula S, Isaacson RS, de Leon MJ, Brinton RDiaz.  2018.  Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study.. PLoS One. 13(12):e0207885.
Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.  2018.  Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.
Capezuti E, Zadeh RSagha, Woody N, Basara A, Krieger AC.  2018.  An Integrative Review of Nonpharmacological Interventions to Improve Sleep among Adults with Advanced Serious Illness.. J Palliat Med. 21(5):700-717.
Merkler AE, Parikh NS, Kamel H.  2018.  Jump Starting Your Clinical Research Career Using Administrative Data Sets for Stroke Research.. Stroke. 49(10):e303-e305.
Mosconi L, Walters M, Sterling J, Quinn C, McHugh P, Andrews RE, Matthews DC, Ganzer C, Osorio RS, Isaacson RS et al..  2018.  Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer's disease: a cross-sectional study of middle-aged adults from the broader New York City area.. BMJ Open. 8(3):e019362.
Deh K, Ponath GD, Molvi Z, Parel G-CT, Gillen KM, Zhang S, Nguyen TD, Spincemaille P, Ma Y, Gupta A et al..  2018.  Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM.. J Magn Reson Imaging. 48(5):1281-1287.
Berti V, Walters M, Sterling J, Quinn CG, Logue M, Andrews R, Matthews DC, Osorio RS, Pupi A, Vallabhajosula S et al..  2018.  Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults.. Neurology. 90(20):e1789-e1798.
Dominguez M, DiCapua D, Leydon G, Loomis C, Longbrake EE, Schaefer SM, Becker KP, Detyniecki K, Gottschalk C, Salardini A et al..  2018.  A Neurology Clerkship Curriculum Using Video-Based Lectures and Just-in-Time Teaching (JiTT).. MedEdPORTAL. 14:10691.
Kang Y, P Mozley D, Verma A, Schlyer D, Henchcliffe C, Gauthier SA, Chiao PC, He B, Nikolopoulou A, Logan J et al..  2018.  Noninvasive PK11195-PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease.. J Neuroimaging. 28(5):496-505.
Zadeh RSagha, Capezuti E, Eshelman P, Woody N, Tiffany J, Krieger AC.  2018.  Non-pharmacological solutions to sleep and circadian rhythm disruption: voiced bedside experiences of hospice and end-of-life staff caregivers.. BMC Palliat Care. 17(1):131.
Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT et al..  2018.  Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.. N Engl J Med. 379(9):846-855.
Merkler AE, Gialdini G, Lerario MP, Parikh NS, Morris NA, Kummer B, Dunn L, Reznik ME, Murthy SB, Navi BB et al..  2018.  Population-Based Assessment of the Long-Term Risk of Seizures in Survivors of Stroke.. Stroke. 49(6):1319-1324.
Chiang GC, Hu J, Morris E, Wang Y, Gauthier SA.  2018.  Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.. AJNR Am J Neuroradiol. 39(3):467-472.
Barone DA, Henchcliffe C.  2018.  Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.. Clin Neurophysiol. 129(8):1551-1564.
Pillai RLI, Malhotra A, Rupert DD, Weschler B, Williams JC, Zhang M, Yang J, J Mann J, Oquendo MA, Parsey RV et al..  2018.  Relations between cortical thickness, serotonin 1A receptor binding, and structural connectivity: A multimodal imaging study.. Hum Brain Mapp. 39(2):1043-1055.
Merkler AE, Gialdini G, Kamel H.  2018.  Response by Merkler et al to Letter Regarding Article, "Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale".. Stroke. 49(1):e17.
Capezuti E, Zadeh RSagha, Pain K, Basara A, Jiang NZiyan, Krieger AC.  2018.  A systematic review of non-pharmacological interventions to improve nighttime sleep among residents of long-term care settings.. BMC Geriatr. 18(1):143.
Ranganathan U, Kaunzner U, Foster S, Vartanian T, Perumal JS.  2018.  Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis.. Mult Scler. 24(4):553-554.